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Treatment of HSV-infected cells with 5-10 mM fl-hydroxynorvaline (Hnv), a threonine analog, specifically 
affects herpesvirus DNA replication: both the rate of and total DNA synthesis are reduced, the former 
15-fold by Hnv (6 h post-infection) and the latter by 12-fold (between 3 and 12 h post-infection). The 
effect on DNA replication was due to inhibition of HSV-1 thymidine kinase (TK) and DNA polymerase 
(DP) activities; the former is reduced by 75% and whereas DP returns to baseline levels (when compared 
to untreated and/or uninfected ceils). Host cell TK and DP activities are unaffected. It is suggested that 
fl-hydroxynorvaline s incorporated into these enzyme(s), either close to or at the active site thus perturbing 
viral DNA synthesis, fl-Hydroxynorvaline should have unique utility as a targeted antiviral compound, 
acting on both membrane-mediated phenomena (fusion, penetration a d attachment) and DNA replication. 
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1. INTRODUCTION 
The incorporation of the threonine analog, B- 
hydroxynorvaline (Hnv), into some secretory pro- 
teins and some viral glycoproteins has been shown 
to inhibit the attachment of mannose-rich 
oligosaccharides to the polypeptide backbone 
[ 1-4]. We previously reported that Hnv inhibits en- 
dogenous fusion and lowers the yield of progeny 
herpesvirus in infected cells - 1-2 logxo. Not only 
was the synthesis of all viral glycoproteins and the 
major capsid protein inhibited [3], but viral DNA 
synthesis also appeared to be affected [4]. 
Infection by HSV-1 results in the synthesis of - 
50 different viral proteins of which about one-half 
are structural [5]. Among these are a viral encoded 
Correspondence address: H.A. Blough, Division of 
Biochemical Virology and Membrane Research, Depart- 
ment of Ophthalmology, University of Pennsylvania 
School of Medicine and Scheie Eye Institute, 
Philadelphia, PA 19104, USA 
thymidine (dThd) kinase (TK) and a DNA- 
dependent DNA polymerase (DP). The primary se- 
quence, kinetic and antigenic properties of these 
viral-induced enzymes are different from those of 
the host cell [6-9]. Because of their unique proper- 
ties, both viral TK and DP have been used as selec- 
tive targets for several different antiherpes 
chemotherapeutic agents viz, 9-(2-hydroxyethoxy- 
methyl)guanine (acyclovir, ACV), (E)-5-(2-bromo- 
vinyl)-2' -deoxyuridine (BVDU), 9-(1,3-dihy- 
droxy-2-propoxymethyl)guanine (DHPG) and 
phosphonoformate (PFA). With the exception of 
PFA, these agents depend upon the specific 
phosphorylation of dThd [10-13]. We now report 
that the amino acid analog, /3-hydroxynorvaline, 
selectively inhibits both TK and DP in either in- 
fected or transfected cells. 
2. MATERIALS AND METHODS 
Green monkey kidney cells (GMK) and HSV-1 
(HF strain) were propagated as described [14]. In 
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some experiments primary rabbit kidney cells were 
used. Biochemically transformed LM(TK- ) /  
TFpMHl l0E2  cells, expressing only HSV-1 TK, 
were kindly supplied by Dr Fred Rapp; these were 
propagated [14,15] and treated with 10 mM Hnv as 
described [14]. TK activity was measured by the 
method of Cohen [16] with minor modifications: 
the reaction mixture contained 0.01 mM dThd and 
2 #Ci [3H]dThd (46 Ci/mmol, Amersham). The 
reaction products were absorbed to DE32 gel 
(Whatman). DP activity was measured by the 
method of Purifoy and Benyesh-Melnick [17] with 
the following modifications: the reaction mixture 
contained 0.3 mM TTP and 5/~Ci [3H]dATP (25.4 
/zCi/mmol, Amersham). Background activity for 
both assays was measured using either a heat- 
activated (100°C for 2 min) extract from infected 
cells (obtained 9 h post-infection) or buffer alone; 
both gave comparable results. The rate of DNA 
synthesis was determined by measuring the incor- 
poration of [3H]thymidine (10 #Ci/ml, 40 
#Ci/mmol, Amersham), following a 30 min pulse 
at various times post-infection, into a trichloro- 
acetic acid-insoluble fraction(s). 
3. RESULTS 
Since the reduction of infectious particles -2  
log~o in Hnv-treated cells could not be entirely at- 
tributed to its effect on glycosylation or on protein 
synthesis [4], we examined other macromolecular 
events, viz., DNA synthesis. The rate of DNA syn- 
thesis was measured, in uninfected and infected 
cells, either treated or not treated with 10 mM 
Hnv, as described above. The results for infected 
cells are shown in fig.1. At 6 h post-infection, 
when the rate of DNA synthesis is maximal in 
HSV-infected cells, there was a 15-fold reduction 
of DNA in Hnv-treated cells. Uninfected cells, 
treated with l0 mM Hnv (not shown), at com- 
parable times, revealed a 20070 decrease in the rate 
of DNA synthesis. Total DNA synthesis at 3-12 h 
post-infection (measured as the area under the 
curves in fig.l) in Hnv-treated cells was reduced 
-12-fo ld.  In comparison to untreated control 
cells, we observed a reduction of total DNA syn- 
thesis of only 1.7 times in Hnv-treated cells. Thus, 
it appears that in addition to inhibition of 
glycosylation, the block in synthesis of HSV 
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Fig.l. Effect of Hnv on the rate of DNA synthesis in 
uninfected (A) and HSV-infected (B) GMK cells. GMK 
cells were infected with HSV as described insection 2. At 
the indicated times the cells were pulsed for 30 min, at 
37°C, with growth medium containing 10 ttCi/ml 
[3H]dThd (Amersham, 46 Ci/mmol), washed with cold 
HBS and solubilized with 1% SDS in 50 mM NaOH. 
The trichloroacetic a id-precipitable radioactivity in 10 
/zl aliquot is shown. Zero time is when the inoculum was 
removed from each plate. ( -O- )  Untreated cells; 
( -O- )  cells treated with 10 mM Hnv. Hnv treatment 
was begun at time zero. 
virions by/~-hydroxynorvaline was due to inhibi- 
tion of DNA synthesis. 
In HSV-infected cells the bulk of the DNA pro- 
duced is viral. We examined the two major viral 
enzymes which are required for DNA replication: 
viral thymidine kinase and DNA polymerase. TK 
activity in Hnv-treated cells was reduced - 75070 
(fig.2); uninfected cells had a TK activity of less 
than 10 cpm per #g protein. To rule out direct ef- 
fects on TK or substrate, 10 mM Hnv was added 
to the reaction mixture (of infected cells). This 
failed to inhibit TK activity (not shown). In HSV- 
infected cells, DP activity was reduced to levels 
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Fig.2. Effecl~ of Hnv on TK in HSV-infected GMK cells. 
GMK cells were infected with HSV as described in sec- 
tion 2. At the times indicated the cells were rinsed with 
TBS (10 mM Tris-HC1, 150 mM NaC1, pH 7.8), 
suspended in 80 mM Tris-HCl, pH 7.8, 2 mM DTT; 
sonicated for 60 s and centrifuged for 2 min in a 
Beckman microfuge. The supernatant was used in the 
enzyme assay. All assays were done in duplicate at each 
time interval. ( -O- )  Untreated, HSV-infected cells; 
( -O- )  HSV-infected cells treated with 10 mM Hnv. 
found in uninfected cells and in cells at 0 h post- 
infection (fig.3). From these studies we conclude 
that Hnv treatment of infected cells reduced DP 
activity to almost nil. The conditions of the reac- 
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Fig.3. Effect of Hnv on DP in HSV-infected GMK cells. 
GMK cells were infected with HSV and treated with Hnv 
as described in fig. 1. At the times indicated the cells were 
washed with TBS, harvested using a rubber policeman, 
resuspended in 10 mM Tris-HC1, 10 mM NaCl, pH 7.4, 
and sonicated for 5 min. The cell extract was assayed for 
DP using heat denatured DNA (salmon sperm, Sigma). 
( -0 - )  Untreated, HSV-infected cells; ( -0 - )  HSV- 
infected cells treated with 10 mM Hnv. 
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Fig.4. Dose response curve of TK activity in 
HSV-l-infected ( -&- )  and uninfected ( -A - )  
primary rabbit kindey cells treated with Hnv. Cells were 
infected with HSV-1 and treated with various concentra- 
tions of Hnv as described in fig. 1. TK activity (y-axis) 
was assayed at 7 h post-infection. 
tion mixture we used were optimal for viral DP 
and inhibitory for host DP(s). The presence of 100 
mM (NH4)2SO4, in the reaction mixture inhibited 
DP activity in uninfected ceils - 8-fold; whereas 
that of HSV-infected cells, was enhanced 2.4 
times. As little as 2.0 mM Hnv blocked TK activity 
in HSV-infected cells by - 20o70 (fig.4). The viral 
origin of TK was confirmed in two ways: Firstly, 
antibody raised in rabbits against he viral TK [us- 
ing an infected heterologous cell extract as an- 
tigen(s) (gift of Dr Graham Darby, Wellcome 
Laboratories, England], totally blocked the TK ac- 
tivity. The reaction mixture was incubated with the 
antiserum for 2-3 h at 20°C and then at 0°C for 
1 h; normal rabbit serum had no effect. Secondly, 
when cells transfected with the plasmid containing 
the TK gene, LM(TK-)TFpMHl l0E2,  were 
treated with 5 mM Hnv, for 10 h and the cell ex- 
tracts examined, as above, TK activity was reduced 
by - 55o70 when compared to untreated, 
transfected cells (Massare and Blough, un- 
published). 
4. DISCUSSION 
From the results of this study, it was apparent 
that B-hydroxynorvaline markedly inhibited viral 
DNA synthesis by altering both thymidine kinase 
and DNA polymerase activities of HSV-1; the lat- 
ter was diminished to almost undetectable vels 
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(by our assay system). There are several plausible 
explanations for this: firstly, the incorporation of 
Hnv into the enzyme(s) produced an aberrant TK 
and/or  DP [as isoenzyme(s)]; secondly, Hnv led to 
the production of less and/or aberrant regulatory 
viral polypeptides; thirdly, Hnv caused the produc- 
tion of altered viral polypeptides which were more 
labile to proteolysis; fourthly, Hnv produced 
alterations in the regulating genes of the DNA 
polymerase which modified the TK; finally, any 
combination of the above leading to decreased syn- 
thesis and/or  activity. 
Recent studies of HSV-1 have shown the 
presence of at least one Thr residue (at position 63) 
within the ATP-binding site of the TK molecule 
[18,19]. In addition, a triplet of Thr residues are 
present at positions 64-66; the latter is directly ad- 
jacent to the ATP-binding site. The subsitution of 
Hnv into the polypeptide chain(s) does alter the 
recognition site for the attachment of N-linked 
oligosaccharides [3]. The replacement of Thr with 
Hnv, at (or proximal to) the active site of these en- 
zyme(s) or regulatory peptide(s), would be ex- 
pected to alter their tertiary and quarternary 
structure thus, inhibiting enzymatic function. 
Similarly, the incorporation of Hnv into ct- 
polypeptides [Translation in HSV-l-infected cells 
occurs in a regulated cascading fashion. The 
polypeptides are grouped into or-, /3- and ~/- 
polypeptides: the ct-polypeptides are synthesized 
first and induce the synthesis of ~-polypeptides. 
The latter induce the synthesis of -r-polypeptides 
and shut-off the translation of ct-polypeptides. The 
-r-polypeptides are made last and inhibit /3- 
polypeptide translation. Viral DNA replication oc- 
curs after the onset of ~-polypeptide synthesis; the 
latter is required for DNA synthesis.] of HSV-1 
may modify the induction of ~-peptides (TK and 
DP) resulting in diminished quantities of TK and 
DP being synthesized. We have been able to 
demonstrate, using the cycloheximide block 
method [20], that the synthesis of ~- and "r- 
polypeptides in HSV-l-infected cells was inhibited 
by 10 mM Hnv (Massare and Blough, unpub- 
lished). However, at this time we are unable to 
ascertain if these peptides are absent or non- 
functional (if synthesized) by SDS-PAGE and 
fluorography. There are several known examples 
where the substitution of a single amino acid in a 
peptide alters its function and physiochemical 
properties. These include sickle-cell hemoglobin 
(valine /3-6 substitution), influenza virus hemag- 
glutinin and SV40 T antigen as well as the HSV-1 
syn polypeptide [21-23]. Thus, /3-hydroxynor- 
valine appears to be targeted at HSV-1 enzymes 
and regulatory polypeptides, with little or no effect 
on uninfected ceils, suggesting that the de novo 
pathway (thymidylate synthetase) [24] was used to 
synthesize DNA. Hnv was not toxic to the cell 
types used in this experiment. However, certain 
cells of lymphocytic origin and cells persistently 
infected with HIV show signs of cytotoxicity at 
concentrations of Hnv above 0.8 mM [25]. This 
selectivity, as well as its marked effects on N- 
linked oligosaccharides, enhances the potential of 
Hnv, as a useful antiviral agent against herpesvirus 
infections. 
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